Delhi’s alleged ₹650 crore medicine fraud draws fresh allegations
Delhi, August 8 – The opposition Aam Aadmi Party has intensified its criticism of the Delhi administration, claiming that a drug procurement scandal amounting to roughly ₹650 crore is only the tip of the iceberg. Party head Saurabh Bhardwaj said that a sizeable chunk of medicines bought for public hospitals never arrived, despite being recorded in official purchase files.
Bhardwaj pointed out a striking price disparity: the state allegedly paid ₹400 crore for medicines whose market value should have been around ₹100 crore, suggesting a hidden commission of about ₹300 crore. He added that after scrutinising the documents of the Sarvodaya Vallabhbhai Patel Hospital, further inconsistencies emerged, casting doubt on the integrity of the entire supply chain.
In his statements, Bhardwaj emphasized that hospital inventories list large monetary values for ordered drugs, yet physical audits revealed the medicines were missing. He also raised concerns about the presence of Maximum Retail Price (MRP) markings on the procured items, a practice that was avoided by the previous AAP‑led government to block resale possibilities.
The party argues that the current approach may allow private chemists to channel government‑purchased drugs into the open market, estimating that 70‑80% of the stock could have been diverted while only 20‑30% reached the intended patients. This, he warned, not only undermines public health but also squanders taxpayer money.
These fresh allegations follow a recent inspection by AAP MLA Kuldeep Kumar, who highlighted acute medicine shortages in multiple Delhi hospitals. Bhardwaj called for a comprehensive probe, demanding clarity on the whereabouts of the missing medicines and accountability from the ruling administration.